These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12447157)

  • 21. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G; Di Lenarda A; Metra M; Nodari S; Moretti M; Brentana L; Dei Cas L; Sinagra G
    Ital Heart J; 2004 Dec; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New studies influencing treatment of heart failure: 2006 update.
    Dunlap ME
    Pharmacotherapy; 2007 Apr; 27(4 Pt 2):3S-11S. PubMed ID: 17381369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF.
    Fonarow GC
    Rev Cardiovasc Med; 2004; 5 Suppl 1():S45-54. PubMed ID: 15184838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences between cardiologists and internists in the management of heart failure. Medical guidelines compared with every-day practice.
    Stawicki S; Roik M; Jasik M; Kosior D; Scisło P; Kochanowski J; Dembe K; Steckiewicz R; Karnafel W; Opolski G
    Kardiol Pol; 2004 Nov; 61(11):431-9; discussion 440-1. PubMed ID: 15883591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. beta-Blocker therapy in heart failure.
    Doughty RN
    Heart Fail Monit; 2000; 1(1):2-7. PubMed ID: 12634875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Do women receive as good treatment for heart diseases as men?].
    Risøe C; Graff-Iversen S
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):785-7. PubMed ID: 16541174
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent advances in the management of chronic heart failure.
    Krum H; Liew D
    Aust Fam Physician; 2003; 32(1-2):39-43. PubMed ID: 12647658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic implications of treatment guidelines for congestive heart failure.
    Shibata MC; Nilsson C; Hervas-Malo M; Jacobs P; Tsuyuki RT
    Can J Cardiol; 2005 Dec; 21(14):1301-6. PubMed ID: 16341301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies to improve the use of evidence-based heart failure therapies.
    Fonarow GC
    Rev Cardiovasc Med; 2005; 6 Suppl 2():S32-42. PubMed ID: 15891703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G; Sabbadini G; Zecchin M; Di Lenarda A
    G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing the patient with diabetes mellitus and heart failure: issues and considerations.
    Fonarow GC
    Am J Med; 2004 Mar; 116 Suppl 5A():76S-88S. PubMed ID: 15019865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for the management of heart failure: differences in guideline perspectives.
    Jessup M; Brozena SC
    Cardiol Clin; 2007 Nov; 25(4):497-506; v. PubMed ID: 18063155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.
    Fonarow GC; Gheorghiade M; Abraham WT
    Am J Cardiol; 2004 Nov; 94(9):1155-60. PubMed ID: 15518610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta blockers in systolic heart failure.
    Jackowski L; Azam R
    Aust Fam Physician; 2008 Mar; 37(3):137-9. PubMed ID: 18345362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of age and in-patient care on prescription rate and long-term outcome in chronic heart failure: a data-based substudy of the EuroHeart Failure Survey.
    Hülsmann M; Berger R; Mörtl D; Pacher R
    Eur J Heart Fail; 2005 Jun; 7(4):657-61. PubMed ID: 15921808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
    Granmyr J; Ball P; Curran S; Wang L
    Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey.
    Sturm HB; van Gilst WH; Veeger N; Haaijer-Ruskamp FM
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):96-103. PubMed ID: 16528759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurohormonal antagonism in heart failure: what is the optimal strategy?
    Sackner-Bernstein JD; Hart D
    Mt Sinai J Med; 2004 Mar; 71(2):115-26. PubMed ID: 15029403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.